EVMN
EVMN
NYSE · Biotechnology

Evommune Inc

$23.33
-0.23 (-0.98%)
As of Mar 22, 10:20 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +224.9% upside
Low Target $52.19
Average Target $75.80
High Target $91.23
Current Price $23.33
Current
$23.33
Target
$75.80
$52.19 $75.80 avg $91.23
Scenario Analysis
Bear Case
$52.19
123.7%
Low target
Base Case
$75.80
+224.9%
Avg target
Bull Case
$91.23
+291.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$33.20
-29.7% from high
52-Week Low
$13.89
+68.0% from low
Target vs 52W High
$75.80
+128.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%